Therefore, accurate discrimination can rely on a combined testing strategy, namely confirming viral CNS localization and active infection by comparing viral loads (e.g., via qPCR) in paired CSF and plasma samples along with EBV serology (VCA-IgM, EBNA-1 IgG) (Wilson et al., 2019). The gene discussed is CD40LG; the disease is infection.